They warn that loss of coverage could worsen health outcomes and raise future health care costs
It will be a useful resource for clinicians and researchers seeking an integrated translational view of how GLP-1RAs may both protect and, under certain clinical circumstances, be associated with ocular adverse events, while emphasizing the need for further mechanistic and long-term outcome data
Kankuri E, Finckenberg P, Leinonen J, Tarkia M, Bjrk S, Purhonen J, et al
However, there are patients in West Virginia who have experienced serious side effects from Zepbound even though they followed instructions to the letter
The impact of a massive spike in GLP-1 adoption in 2025 goes well beyond food